How Infosys optimizes quality and compliance in Healthcare and Life Sciences

Enterprises in highly regulated industries like healthcare and life sciences face unique challenges in maintaining quality assurance during digital transformation initiatives. Fragmented toolsets impact traceability and audit readiness and manual approval workflows slow down test cycles. Plus, there is limited automation in validated environments due to the persistence of traditional paper-based validation. Organizations challenged by quality could risk fines or legal consequences if they do not follow compliance with regulations such as FDA 21 CFR Part 11.

A global leader in next-generation digital services and consulting, Infosys empowers enterprises worldwide to accelerate their quality assurance journeys. As a trusted Tricentis partner, Infosys brings deep domain expertise in highly regulated industries, delivering innovative solutions across cloud, AI, automation, and quality engineering. Their commitment to measurable outcomes and transformation at scale makes them a strategic force in driving digital excellence.

A strategic edge: Tricentis and Infosys partnership

Since 2012, Tricentis and Infosys have been strategic partners collaborating to elevate quality engineering across industries. The partnership is driven by a shared vision to accelerate digital transformation through intelligent test automation and continuous testing. Infosys complements Tricentis by offering implementation, migration, and enablement services to deliver scalable, AI-powered quality engineering solutions that reduce time-to-market and enhance software reliability.

Partnering with Tricentis has enabled Infosys to expand its quality engineering portfolio with AI-driven, low-code automation solutions, giving it a strategic edge in winning transformation deals, especially in sectors like healthcare where speed and compliance are critical. Tricentis has empowered Infosys to deliver quality and help its clients innovate confidently in complex, highly regulated environments.

Infosys has been the recipient of multiple prestigious Tricentis awards, including:

• Global Certification Champion 2024
• AMS Performance Testing Partner 2024
• Life Sciences Global Partner of the Year 2023
• Solution Award 2023 for the seamless integration of Tricentis Neoload with Infosys Cloud Infrastructure Validation
• Technical Award 2023 for the performance testing solution of Google Remote Procedure Call using Neoload

How Infosys helped transform a global life sciences company

A global life sciences company needed to automate its testing of SAP S/4HANA and legacy systems. The company was challenged by setting up a Google Cloud Platform and ensuring adherence to life sciences regulations and compliance standards. As a GxP-regulated client, all implementations and validations had to be fully compliant with regulatory requirements.

The life sciences company had an ongoing engagement with Infosys AMS. Infosys implemented an integrated solution using Tricentis Tosca, Tricentis qTest, Tricentis Vera, and JIRA to automate its SAP S/4HANA and legacy systems testing. The testing team was responsible for baselining test cases for automation and migrating test artifacts from HP ALM to Tricentis qTest. Infosys integrated Tosca, qTest, and Vera to support the company’s requirement, pre-execution, and post-execution approval processes.

The solution included:

• Migrating test assets from ALM to qTest with zero data loss including approximately 5,000 requirements, 5,670 test cases, 54,128 test runs, and 334,861 attachments
• Automating 80% of SAP regression suite, enabling monthly cycles
• Enabling digital validation with e-signatures via Vera
• Streamlining multi-level approval flows to ensure compliance

Infosys conducted automation testing for the SAP technical upgrade, executing approximately 1,000 test cases and 100 business scenarios. These were executed across three landscapes, enabling early identification of critical defects and ensuring a defect-free product was delivered to production.

To ensure compliance, Infosys followed the IQ/OQ/PQ validation process as per the client requirements and leveraged the Veeva document approval workflow. The transformation enabled digital signatures for all test attributes — requirements, test scripts, and test executions, eliminating the need for paper-based documentation.

Infosys’ approach accelerated the life sciences client’s Agile and DevOps adoption while maintaining regulatory integrity demonstrating how Tricentis’ solutions can drive innovation and speed in mission-critical, regulated environments.

AI trends shaping the future of quality engineering in healthcare

AI continues to influence how highly regulated industries like healthcare approach building, testing, and delivering software. To find out more, the AI-augmented DevOps: Trends Shaping The Future Report commissioned by Tricentis with TechStrong Research, surveyed IT professionals, including those in the healthcare and pharmaceutical industries, to understand the anticipated benefits of AI in DevOps.

Insights from the report include:

• 42% of respondents said AI-augmented DevOps helps to overcome the challenges of improving software quality.
• Nearly a quarter (24%) of all respondents indicate they are currently using AI in one or more areas of the SDLC.
• Development and testing are the most common use cases for AI technologies, with nearly half (44.7%) of teams adopting AI to augment development and over one-third (39.7%) using it in testing.
• 27% of respondents use AI in DevOps for creating reports for security, governance, or compliance.

As AI and quality remain top priorities for highly regulated sectors, Infosys envisions a future where intelligent quality engineering becomes a cornerstone of digital transformation, and its joint offerings with Tricentis will continue to help clients achieve continuous quality across the software lifecycle.